SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001479290-17-000023
Filing Date
2017-05-09
Accepted
2017-05-09 17:12:29
Documents
65
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rvncq11710q.htm 10-Q 969173
2 EXHIBIT 10.2 rvnc-q117exhibit1025.htm EX-10.2 15608
3 EXHIBIT 10.4 rnvc-q117exhibit104.htm EX-10.4 228404
4 EXHIBIT 31.1 rvnc-q117exhibit311.htm EX-31.1 13578
5 EXHIBIT 31.2 rvnc-q117exhibit312.htm EX-31.2 13475
6 EXHIBIT 32.1 rvnc-q117exhibit321.htm EX-32.1 6236
7 EXHIBIT 32.2 rvnc-q117exhibit322.htm EX-32.2 6261
  Complete submission text file 0001479290-17-000023.txt   4530226

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT rvnc-20170331.xml EX-101.INS 778836
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rvnc-20170331.xsd EX-101.SCH 39035
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rvnc-20170331_cal.xml EX-101.CAL 59277
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rvnc-20170331_def.xml EX-101.DEF 147622
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rvnc-20170331_lab.xml EX-101.LAB 454926
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rvnc-20170331_pre.xml EX-101.PRE 261420
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36297 | Film No.: 17827470
SIC: 2834 Pharmaceutical Preparations